nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—ABCB1—Methylprednisolone—psoriatic arthritis	0.0894	0.254	CbGbCtD
Maprotiline—ABCB1—Betamethasone—psoriatic arthritis	0.0581	0.165	CbGbCtD
Maprotiline—ABCB1—Prednisolone—psoriatic arthritis	0.0573	0.163	CbGbCtD
Maprotiline—ABCB1—Prednisone—psoriatic arthritis	0.0541	0.154	CbGbCtD
Maprotiline—ABCB1—Dexamethasone—psoriatic arthritis	0.0338	0.0961	CbGbCtD
Maprotiline—CYP2D6—Dexamethasone—psoriatic arthritis	0.0318	0.0905	CbGbCtD
Maprotiline—ABCB1—Methotrexate—psoriatic arthritis	0.0272	0.0772	CbGbCtD
Maprotiline—Vision blurred—Prednisolone—psoriatic arthritis	0.00132	0.00204	CcSEcCtD
Maprotiline—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00132	0.00203	CcSEcCtD
Maprotiline—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.0013	0.00201	CcSEcCtD
Maprotiline—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00128	0.00198	CcSEcCtD
Maprotiline—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00128	0.00198	CcSEcCtD
Maprotiline—Myocardial infarction—Prednisone—psoriatic arthritis	0.00128	0.00197	CcSEcCtD
Maprotiline—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00128	0.00197	CcSEcCtD
Maprotiline—Breast disorder—Methotrexate—psoriatic arthritis	0.00128	0.00197	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00127	0.00196	CcSEcCtD
Maprotiline—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00126	0.00194	CcSEcCtD
Maprotiline—Syncope—Prednisolone—psoriatic arthritis	0.00126	0.00194	CcSEcCtD
Maprotiline—Eye disorder—Betamethasone—psoriatic arthritis	0.00125	0.00193	CcSEcCtD
Maprotiline—Eye disorder—Dexamethasone—psoriatic arthritis	0.00125	0.00193	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00123	0.0019	CcSEcCtD
Maprotiline—Angiopathy—Betamethasone—psoriatic arthritis	0.00122	0.00188	CcSEcCtD
Maprotiline—Angiopathy—Dexamethasone—psoriatic arthritis	0.00122	0.00188	CcSEcCtD
Maprotiline—Convulsion—Prednisolone—psoriatic arthritis	0.00121	0.00187	CcSEcCtD
Maprotiline—Hypertension—Prednisolone—psoriatic arthritis	0.00121	0.00186	CcSEcCtD
Maprotiline—Eosinophilia—Methotrexate—psoriatic arthritis	0.00121	0.00186	CcSEcCtD
Maprotiline—Arrhythmia—Dexamethasone—psoriatic arthritis	0.0012	0.00185	CcSEcCtD
Maprotiline—Arrhythmia—Betamethasone—psoriatic arthritis	0.0012	0.00185	CcSEcCtD
Maprotiline—Alopecia—Betamethasone—psoriatic arthritis	0.00119	0.00183	CcSEcCtD
Maprotiline—Alopecia—Dexamethasone—psoriatic arthritis	0.00119	0.00183	CcSEcCtD
Maprotiline—Hallucination—Prednisone—psoriatic arthritis	0.00116	0.00179	CcSEcCtD
Maprotiline—Pancytopenia—Methotrexate—psoriatic arthritis	0.00116	0.00179	CcSEcCtD
Maprotiline—Syncope—Triamcinolone—psoriatic arthritis	0.00115	0.00178	CcSEcCtD
Maprotiline—Syncope—Methylprednisolone—psoriatic arthritis	0.00115	0.00178	CcSEcCtD
Maprotiline—Oedema—Prednisolone—psoriatic arthritis	0.00114	0.00176	CcSEcCtD
Maprotiline—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00113	0.00175	CcSEcCtD
Maprotiline—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00113	0.00174	CcSEcCtD
Maprotiline—Shock—Prednisolone—psoriatic arthritis	0.00112	0.00173	CcSEcCtD
Maprotiline—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00112	0.00173	CcSEcCtD
Maprotiline—Convulsion—Triamcinolone—psoriatic arthritis	0.00112	0.00172	CcSEcCtD
Maprotiline—Tachycardia—Prednisolone—psoriatic arthritis	0.00111	0.00172	CcSEcCtD
Maprotiline—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00111	0.00172	CcSEcCtD
Maprotiline—Convulsion—Methylprednisolone—psoriatic arthritis	0.00111	0.00172	CcSEcCtD
Maprotiline—Hypertension—Triamcinolone—psoriatic arthritis	0.00111	0.00171	CcSEcCtD
Maprotiline—Hypertension—Methylprednisolone—psoriatic arthritis	0.00111	0.00171	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.0011	0.0017	CcSEcCtD
Maprotiline—Eye disorder—Prednisone—psoriatic arthritis	0.00109	0.00168	CcSEcCtD
Maprotiline—Anxiety—Methylprednisolone—psoriatic arthritis	0.00109	0.00168	CcSEcCtD
Maprotiline—Infestation—Methotrexate—psoriatic arthritis	0.00109	0.00168	CcSEcCtD
Maprotiline—Infestation NOS—Methotrexate—psoriatic arthritis	0.00109	0.00168	CcSEcCtD
Maprotiline—Drowsiness—Methotrexate—psoriatic arthritis	0.00109	0.00168	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00109	0.00168	CcSEcCtD
Maprotiline—Flushing—Prednisone—psoriatic arthritis	0.00108	0.00167	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00108	0.00166	CcSEcCtD
Maprotiline—Dry mouth—Triamcinolone—psoriatic arthritis	0.00107	0.00165	CcSEcCtD
Maprotiline—Stomatitis—Methotrexate—psoriatic arthritis	0.00106	0.00164	CcSEcCtD
Maprotiline—Angiopathy—Prednisone—psoriatic arthritis	0.00106	0.00164	CcSEcCtD
Maprotiline—Confusional state—Methylprednisolone—psoriatic arthritis	0.00106	0.00163	CcSEcCtD
Maprotiline—Oedema—Triamcinolone—psoriatic arthritis	0.00105	0.00162	CcSEcCtD
Maprotiline—Syncope—Betamethasone—psoriatic arthritis	0.00105	0.00162	CcSEcCtD
Maprotiline—Syncope—Dexamethasone—psoriatic arthritis	0.00105	0.00162	CcSEcCtD
Maprotiline—Arrhythmia—Prednisone—psoriatic arthritis	0.00104	0.00161	CcSEcCtD
Maprotiline—Infection—Triamcinolone—psoriatic arthritis	0.00104	0.00161	CcSEcCtD
Maprotiline—Infection—Methylprednisolone—psoriatic arthritis	0.00104	0.00161	CcSEcCtD
Maprotiline—Shock—Triamcinolone—psoriatic arthritis	0.00103	0.00159	CcSEcCtD
Maprotiline—Insomnia—Prednisolone—psoriatic arthritis	0.00103	0.00159	CcSEcCtD
Maprotiline—Alopecia—Prednisone—psoriatic arthritis	0.00103	0.00159	CcSEcCtD
Maprotiline—Shock—Methylprednisolone—psoriatic arthritis	0.00103	0.00159	CcSEcCtD
Maprotiline—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00103	0.00159	CcSEcCtD
Maprotiline—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00103	0.00159	CcSEcCtD
Maprotiline—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00103	0.00158	CcSEcCtD
Maprotiline—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00103	0.00158	CcSEcCtD
Maprotiline—Paraesthesia—Prednisolone—psoriatic arthritis	0.00103	0.00158	CcSEcCtD
Maprotiline—Tachycardia—Triamcinolone—psoriatic arthritis	0.00103	0.00158	CcSEcCtD
Maprotiline—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00102	0.00158	CcSEcCtD
Maprotiline—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00102	0.00157	CcSEcCtD
Maprotiline—Malnutrition—Prednisone—psoriatic arthritis	0.00102	0.00157	CcSEcCtD
Maprotiline—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00102	0.00157	CcSEcCtD
Maprotiline—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00102	0.00157	CcSEcCtD
Maprotiline—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00101	0.00156	CcSEcCtD
Maprotiline—Convulsion—Betamethasone—psoriatic arthritis	0.00101	0.00156	CcSEcCtD
Maprotiline—Convulsion—Dexamethasone—psoriatic arthritis	0.00101	0.00156	CcSEcCtD
Maprotiline—Hypertension—Dexamethasone—psoriatic arthritis	0.00101	0.00156	CcSEcCtD
Maprotiline—Hypertension—Betamethasone—psoriatic arthritis	0.00101	0.00156	CcSEcCtD
Maprotiline—Anxiety—Dexamethasone—psoriatic arthritis	0.000991	0.00153	CcSEcCtD
Maprotiline—Anxiety—Betamethasone—psoriatic arthritis	0.000991	0.00153	CcSEcCtD
Maprotiline—Hypotension—Methylprednisolone—psoriatic arthritis	0.00098	0.00151	CcSEcCtD
Maprotiline—Hepatitis—Methotrexate—psoriatic arthritis	0.000977	0.00151	CcSEcCtD
Maprotiline—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000964	0.00149	CcSEcCtD
Maprotiline—Vision blurred—Prednisone—psoriatic arthritis	0.000959	0.00148	CcSEcCtD
Maprotiline—Urethral disorder—Methotrexate—psoriatic arthritis	0.000957	0.00148	CcSEcCtD
Maprotiline—Oedema—Dexamethasone—psoriatic arthritis	0.000953	0.00147	CcSEcCtD
Maprotiline—Oedema—Betamethasone—psoriatic arthritis	0.000953	0.00147	CcSEcCtD
Maprotiline—Insomnia—Triamcinolone—psoriatic arthritis	0.00095	0.00147	CcSEcCtD
Maprotiline—Insomnia—Methylprednisolone—psoriatic arthritis	0.000948	0.00146	CcSEcCtD
Maprotiline—Infection—Betamethasone—psoriatic arthritis	0.000947	0.00146	CcSEcCtD
Maprotiline—Infection—Dexamethasone—psoriatic arthritis	0.000947	0.00146	CcSEcCtD
Maprotiline—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000943	0.00146	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000941	0.00145	CcSEcCtD
Maprotiline—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000941	0.00145	CcSEcCtD
Maprotiline—Shock—Dexamethasone—psoriatic arthritis	0.000938	0.00145	CcSEcCtD
Maprotiline—Shock—Betamethasone—psoriatic arthritis	0.000938	0.00145	CcSEcCtD
Maprotiline—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000935	0.00144	CcSEcCtD
Maprotiline—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000935	0.00144	CcSEcCtD
Maprotiline—Agitation—Prednisone—psoriatic arthritis	0.000935	0.00144	CcSEcCtD
Maprotiline—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000933	0.00144	CcSEcCtD
Maprotiline—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000933	0.00144	CcSEcCtD
Maprotiline—Tachycardia—Betamethasone—psoriatic arthritis	0.00093	0.00144	CcSEcCtD
Maprotiline—Tachycardia—Dexamethasone—psoriatic arthritis	0.00093	0.00144	CcSEcCtD
Maprotiline—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000925	0.00143	CcSEcCtD
Maprotiline—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000923	0.00142	CcSEcCtD
Maprotiline—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000923	0.00142	CcSEcCtD
Maprotiline—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000922	0.00142	CcSEcCtD
Maprotiline—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000922	0.00142	CcSEcCtD
Maprotiline—Eye disorder—Methotrexate—psoriatic arthritis	0.000913	0.00141	CcSEcCtD
Maprotiline—Syncope—Prednisone—psoriatic arthritis	0.000912	0.00141	CcSEcCtD
Maprotiline—Tinnitus—Methotrexate—psoriatic arthritis	0.00091	0.0014	CcSEcCtD
Maprotiline—Urticaria—Prednisolone—psoriatic arthritis	0.000908	0.0014	CcSEcCtD
Maprotiline—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000906	0.0014	CcSEcCtD
Maprotiline—Fatigue—Triamcinolone—psoriatic arthritis	0.000906	0.0014	CcSEcCtD
Maprotiline—Fatigue—Methylprednisolone—psoriatic arthritis	0.000904	0.00139	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisone—psoriatic arthritis	0.000894	0.00138	CcSEcCtD
Maprotiline—Hypotension—Betamethasone—psoriatic arthritis	0.000891	0.00137	CcSEcCtD
Maprotiline—Hypotension—Dexamethasone—psoriatic arthritis	0.000891	0.00137	CcSEcCtD
Maprotiline—Angiopathy—Methotrexate—psoriatic arthritis	0.000886	0.00137	CcSEcCtD
Maprotiline—Convulsion—Prednisone—psoriatic arthritis	0.000881	0.00136	CcSEcCtD
Maprotiline—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00088	0.00136	CcSEcCtD
Maprotiline—Hypertension—Prednisone—psoriatic arthritis	0.000878	0.00135	CcSEcCtD
Maprotiline—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000866	0.00134	CcSEcCtD
Maprotiline—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000864	0.00133	CcSEcCtD
Maprotiline—Anxiety—Prednisone—psoriatic arthritis	0.000863	0.00133	CcSEcCtD
Maprotiline—Alopecia—Methotrexate—psoriatic arthritis	0.000863	0.00133	CcSEcCtD
Maprotiline—Insomnia—Dexamethasone—psoriatic arthritis	0.000862	0.00133	CcSEcCtD
Maprotiline—Insomnia—Betamethasone—psoriatic arthritis	0.000862	0.00133	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00086	0.00133	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000857	0.00132	CcSEcCtD
Maprotiline—Paraesthesia—Betamethasone—psoriatic arthritis	0.000856	0.00132	CcSEcCtD
Maprotiline—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000856	0.00132	CcSEcCtD
Maprotiline—Malnutrition—Methotrexate—psoriatic arthritis	0.00085	0.00131	CcSEcCtD
Maprotiline—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000839	0.00129	CcSEcCtD
Maprotiline—Dyspepsia—Betamethasone—psoriatic arthritis	0.000839	0.00129	CcSEcCtD
Maprotiline—Urticaria—Triamcinolone—psoriatic arthritis	0.000835	0.00129	CcSEcCtD
Maprotiline—Urticaria—Methylprednisolone—psoriatic arthritis	0.000833	0.00128	CcSEcCtD
Maprotiline—Dysgeusia—Methotrexate—psoriatic arthritis	0.000832	0.00128	CcSEcCtD
Maprotiline—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00083	0.00128	CcSEcCtD
Maprotiline—Oedema—Prednisone—psoriatic arthritis	0.00083	0.00128	CcSEcCtD
Maprotiline—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000829	0.00128	CcSEcCtD
Maprotiline—Infection—Prednisone—psoriatic arthritis	0.000825	0.00127	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000823	0.00127	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000823	0.00127	CcSEcCtD
Maprotiline—Fatigue—Betamethasone—psoriatic arthritis	0.000822	0.00127	CcSEcCtD
Maprotiline—Fatigue—Dexamethasone—psoriatic arthritis	0.000822	0.00127	CcSEcCtD
Maprotiline—Shock—Prednisone—psoriatic arthritis	0.000817	0.00126	CcSEcCtD
Maprotiline—Nervous system disorder—Prednisone—psoriatic arthritis	0.000814	0.00126	CcSEcCtD
Maprotiline—Tachycardia—Prednisone—psoriatic arthritis	0.00081	0.00125	CcSEcCtD
Maprotiline—Skin disorder—Prednisone—psoriatic arthritis	0.000806	0.00124	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000803	0.00124	CcSEcCtD
Maprotiline—Vision blurred—Methotrexate—psoriatic arthritis	0.000801	0.00124	CcSEcCtD
Maprotiline—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000786	0.00121	CcSEcCtD
Maprotiline—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000786	0.00121	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000779	0.0012	CcSEcCtD
Maprotiline—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000779	0.0012	CcSEcCtD
Maprotiline—Leukopenia—Methotrexate—psoriatic arthritis	0.000761	0.00117	CcSEcCtD
Maprotiline—Urticaria—Betamethasone—psoriatic arthritis	0.000757	0.00117	CcSEcCtD
Maprotiline—Urticaria—Dexamethasone—psoriatic arthritis	0.000757	0.00117	CcSEcCtD
Maprotiline—Dizziness—Prednisolone—psoriatic arthritis	0.000755	0.00117	CcSEcCtD
Maprotiline—Asthenia—Triamcinolone—psoriatic arthritis	0.000754	0.00116	CcSEcCtD
Maprotiline—Abdominal pain—Betamethasone—psoriatic arthritis	0.000754	0.00116	CcSEcCtD
Maprotiline—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000754	0.00116	CcSEcCtD
Maprotiline—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000754	0.00116	CcSEcCtD
Maprotiline—Body temperature increased—Betamethasone—psoriatic arthritis	0.000754	0.00116	CcSEcCtD
Maprotiline—Asthenia—Methylprednisolone—psoriatic arthritis	0.000752	0.00116	CcSEcCtD
Maprotiline—Insomnia—Prednisone—psoriatic arthritis	0.000751	0.00116	CcSEcCtD
Maprotiline—Paraesthesia—Prednisone—psoriatic arthritis	0.000745	0.00115	CcSEcCtD
Maprotiline—Pruritus—Triamcinolone—psoriatic arthritis	0.000743	0.00115	CcSEcCtD
Maprotiline—Pruritus—Methylprednisolone—psoriatic arthritis	0.000742	0.00114	CcSEcCtD
Maprotiline—Convulsion—Methotrexate—psoriatic arthritis	0.000737	0.00114	CcSEcCtD
Maprotiline—Dyspepsia—Prednisone—psoriatic arthritis	0.000731	0.00113	CcSEcCtD
Maprotiline—Rash—Prednisolone—psoriatic arthritis	0.00072	0.00111	CcSEcCtD
Maprotiline—Dermatitis—Prednisolone—psoriatic arthritis	0.00072	0.00111	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000719	0.00111	CcSEcCtD
Maprotiline—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000717	0.00111	CcSEcCtD
Maprotiline—Fatigue—Prednisone—psoriatic arthritis	0.000716	0.0011	CcSEcCtD
Maprotiline—Headache—Prednisolone—psoriatic arthritis	0.000716	0.0011	CcSEcCtD
Maprotiline—Constipation—Prednisone—psoriatic arthritis	0.00071	0.0011	CcSEcCtD
Maprotiline—Confusional state—Methotrexate—psoriatic arthritis	0.0007	0.00108	CcSEcCtD
Maprotiline—Dizziness—Triamcinolone—psoriatic arthritis	0.000695	0.00107	CcSEcCtD
Maprotiline—Dizziness—Methylprednisolone—psoriatic arthritis	0.000693	0.00107	CcSEcCtD
Maprotiline—Infection—Methotrexate—psoriatic arthritis	0.000689	0.00106	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisone—psoriatic arthritis	0.000684	0.00106	CcSEcCtD
Maprotiline—Asthenia—Betamethasone—psoriatic arthritis	0.000684	0.00106	CcSEcCtD
Maprotiline—Asthenia—Dexamethasone—psoriatic arthritis	0.000684	0.00106	CcSEcCtD
Maprotiline—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00068	0.00105	CcSEcCtD
Maprotiline—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000679	0.00105	CcSEcCtD
Maprotiline—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000679	0.00105	CcSEcCtD
Maprotiline—Nausea—Prednisolone—psoriatic arthritis	0.000679	0.00105	CcSEcCtD
Maprotiline—Pruritus—Betamethasone—psoriatic arthritis	0.000674	0.00104	CcSEcCtD
Maprotiline—Pruritus—Dexamethasone—psoriatic arthritis	0.000674	0.00104	CcSEcCtD
Maprotiline—Skin disorder—Methotrexate—psoriatic arthritis	0.000674	0.00104	CcSEcCtD
Maprotiline—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000671	0.00103	CcSEcCtD
Maprotiline—Vomiting—Triamcinolone—psoriatic arthritis	0.000668	0.00103	CcSEcCtD
Maprotiline—Vomiting—Methylprednisolone—psoriatic arthritis	0.000666	0.00103	CcSEcCtD
Maprotiline—Rash—Triamcinolone—psoriatic arthritis	0.000662	0.00102	CcSEcCtD
Maprotiline—Dermatitis—Triamcinolone—psoriatic arthritis	0.000662	0.00102	CcSEcCtD
Maprotiline—Rash—Methylprednisolone—psoriatic arthritis	0.000661	0.00102	CcSEcCtD
Maprotiline—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00066	0.00102	CcSEcCtD
Maprotiline—Urticaria—Prednisone—psoriatic arthritis	0.000659	0.00102	CcSEcCtD
Maprotiline—Headache—Triamcinolone—psoriatic arthritis	0.000658	0.00102	CcSEcCtD
Maprotiline—Headache—Methylprednisolone—psoriatic arthritis	0.000657	0.00101	CcSEcCtD
Maprotiline—Abdominal pain—Prednisone—psoriatic arthritis	0.000656	0.00101	CcSEcCtD
Maprotiline—Body temperature increased—Prednisone—psoriatic arthritis	0.000656	0.00101	CcSEcCtD
Maprotiline—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000652	0.00101	CcSEcCtD
Maprotiline—Diarrhoea—Betamethasone—psoriatic arthritis	0.000652	0.00101	CcSEcCtD
Maprotiline—Hypotension—Methotrexate—psoriatic arthritis	0.000648	0.001	CcSEcCtD
Maprotiline—Dizziness—Betamethasone—psoriatic arthritis	0.00063	0.000972	CcSEcCtD
Maprotiline—Dizziness—Dexamethasone—psoriatic arthritis	0.00063	0.000972	CcSEcCtD
Maprotiline—Insomnia—Methotrexate—psoriatic arthritis	0.000627	0.000968	CcSEcCtD
Maprotiline—Nausea—Triamcinolone—psoriatic arthritis	0.000624	0.000963	CcSEcCtD
Maprotiline—Paraesthesia—Methotrexate—psoriatic arthritis	0.000623	0.000961	CcSEcCtD
Maprotiline—Nausea—Methylprednisolone—psoriatic arthritis	0.000623	0.000961	CcSEcCtD
Maprotiline—Somnolence—Methotrexate—psoriatic arthritis	0.000617	0.000952	CcSEcCtD
Maprotiline—Dyspepsia—Methotrexate—psoriatic arthritis	0.000611	0.000942	CcSEcCtD
Maprotiline—Vomiting—Dexamethasone—psoriatic arthritis	0.000606	0.000935	CcSEcCtD
Maprotiline—Vomiting—Betamethasone—psoriatic arthritis	0.000606	0.000935	CcSEcCtD
Maprotiline—Rash—Dexamethasone—psoriatic arthritis	0.000601	0.000927	CcSEcCtD
Maprotiline—Rash—Betamethasone—psoriatic arthritis	0.000601	0.000927	CcSEcCtD
Maprotiline—Dermatitis—Dexamethasone—psoriatic arthritis	0.0006	0.000926	CcSEcCtD
Maprotiline—Dermatitis—Betamethasone—psoriatic arthritis	0.0006	0.000926	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000599	0.000924	CcSEcCtD
Maprotiline—Fatigue—Methotrexate—psoriatic arthritis	0.000598	0.000923	CcSEcCtD
Maprotiline—Headache—Dexamethasone—psoriatic arthritis	0.000597	0.000921	CcSEcCtD
Maprotiline—Headache—Betamethasone—psoriatic arthritis	0.000597	0.000921	CcSEcCtD
Maprotiline—Asthenia—Prednisone—psoriatic arthritis	0.000596	0.000919	CcSEcCtD
Maprotiline—Pruritus—Prednisone—psoriatic arthritis	0.000587	0.000906	CcSEcCtD
Maprotiline—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000572	0.000882	CcSEcCtD
Maprotiline—Diarrhoea—Prednisone—psoriatic arthritis	0.000568	0.000876	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000567	0.000875	CcSEcCtD
Maprotiline—Nausea—Betamethasone—psoriatic arthritis	0.000566	0.000874	CcSEcCtD
Maprotiline—Nausea—Dexamethasone—psoriatic arthritis	0.000566	0.000874	CcSEcCtD
Maprotiline—Urticaria—Methotrexate—psoriatic arthritis	0.000551	0.00085	CcSEcCtD
Maprotiline—Dizziness—Prednisone—psoriatic arthritis	0.000549	0.000847	CcSEcCtD
Maprotiline—Abdominal pain—Methotrexate—psoriatic arthritis	0.000548	0.000846	CcSEcCtD
Maprotiline—Body temperature increased—Methotrexate—psoriatic arthritis	0.000548	0.000846	CcSEcCtD
Maprotiline—Vomiting—Prednisone—psoriatic arthritis	0.000528	0.000814	CcSEcCtD
Maprotiline—Rash—Prednisone—psoriatic arthritis	0.000523	0.000808	CcSEcCtD
Maprotiline—Dermatitis—Prednisone—psoriatic arthritis	0.000523	0.000807	CcSEcCtD
Maprotiline—Headache—Prednisone—psoriatic arthritis	0.00052	0.000802	CcSEcCtD
Maprotiline—Asthenia—Methotrexate—psoriatic arthritis	0.000498	0.000768	CcSEcCtD
Maprotiline—Nausea—Prednisone—psoriatic arthritis	0.000493	0.000761	CcSEcCtD
Maprotiline—Pruritus—Methotrexate—psoriatic arthritis	0.000491	0.000757	CcSEcCtD
Maprotiline—Diarrhoea—Methotrexate—psoriatic arthritis	0.000475	0.000732	CcSEcCtD
Maprotiline—Dizziness—Methotrexate—psoriatic arthritis	0.000459	0.000708	CcSEcCtD
Maprotiline—Vomiting—Methotrexate—psoriatic arthritis	0.000441	0.000681	CcSEcCtD
Maprotiline—Rash—Methotrexate—psoriatic arthritis	0.000437	0.000675	CcSEcCtD
Maprotiline—Dermatitis—Methotrexate—psoriatic arthritis	0.000437	0.000674	CcSEcCtD
Maprotiline—Headache—Methotrexate—psoriatic arthritis	0.000435	0.000671	CcSEcCtD
Maprotiline—Nausea—Methotrexate—psoriatic arthritis	0.000412	0.000636	CcSEcCtD
